Počet záznamov: 1

palivizumab

SYS		d000069455
LBL		00000nx^^^2200181-^^45^^
005		20240119195247.0
100		$a 20160101asloy0103 ba0
152		$b mesh
250		$a palivizumab $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x TO $x TU $x UL $x UR $8 slo
300	1-	$a 2016 (1998) $8 eng
330	1-	$a A humanized monoclonal antibody and ANTIVIRAL AGENT that is used to prevent RESPIRATORY SYNCYTIAL VIRUS INFECTIONS in high risk pediatric patients. $8 eng
450		$a MEDI 493 $5 e $8 slo
450		$a protilátka monoklonálna, MEDI-493 $5 e $8 slo
686		$a D12.776.124.486.485.114.224.060.860
686		$a D12.776.124.790.651.114.224.060.860
686		$a D12.776.377.715.548.114.224.200.860
750		$a Palivizumab $8 eng
801	-0	$a SK $b BA006 $c 20160207
801	-2	$a SK $b BA006 $c 20160209
980		$x M

Počet záznamov: 1